NOMECO A/S
CVR: 20678232
Secondary names: MECOBENZON A/S, NORDISK DROGE & KEMIKALIE A/S, NORTHERN DRUGS & CHEMICALS LIMITED A/S
Previous names: A/S PSE NR. 5314, NOMECO A/S AF 1998
NOMECO A/S demonstrates a strong upward trajectory in financial health, with revenue increasing from 7.57 billion DKK in 2021 to 11.47 billion DKK in 2025. Profitability has also improved significantly, rising from 31.5 million DKK in 2021 to 102 million DKK in 2025, indicating enhanced operational efficiency and margin growth. The company's equity has steadily increased, reaching 753.9 million DKK in 2025, reflecting a solid capital position. As a key player in the wholesale trade of pharmaceuticals and medical supplies, NOMECO A/S is well-positioned within its industry, although ongoing monitoring of market conditions and competition is essential for sustained growth.
AI-generated summary
Overview
Details
Contact
Purpose
Selskabets formål er (a) handel med lægemidler i grossistleddet, (b) handel med kemikalier, (c) handel med beslægtede varer og (d) fremstilling af sådanne produkter.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 11.5 mia. | 102 mio. | 5.2 mia. | 753.9 mio. | 665 | |
History
Ownership
Properties
(6)· 4 historic6 properties
Upgrade to Pro to see addresses, building data and ownership details
Management
Directors
Board
Founders
Production units (13)
Similar companies
Companies in the same industry and area